Hey Chill, BDAZ...we're all after the same thing...namely a stable and slowly increasing share price.
Again: Here's I heard and saw that wasn't there before on a past R@R:
1) Second licensing agreement "soon" (whatever than means but I expect it in late Sept. Oct or November
2. Specific details regarding FDA meetings and the agenda "this fall" (meaning anytime up thru Dec.)
3. Confirmation of the animal tests that the FDA required, which I interpret as being closer to approval than before.
Probably, most importantly, the delay in the AGM has fueled lots of speculation about a possible "something". All this was a positive that was not discussed in the same detail as previously.
I don't have a clue about what happend today except to say that 1) a few trades in such a thin stock make the share price move wildly but 2) I know nothing about clever stock munipulation which "may have" happened today.
I'm still long and strong, but will probably NOT wait to unloaded my holdings unti mid 2018....hope for a positive futility analysis and a positive FDA report...should really help us here.
